blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2021368

EP2021368 - DERIVATIZED INSULIN OLIGOMERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.05.2013
Database last updated on 23.04.2024
Most recent event   Tooltip24.05.2013Application deemed to be withdrawnpublished on 26.06.2013  [2013/26]
Applicant(s)For all designated states
Diabecore Medical Inc.
120 Eglington Ave E.
Toronto ON M4P 1E2 / CA
[2009/07]
Inventor(s)01 / LOUGHEED, William D.
28 Crestview Road
Toronto, Ontario M5N 1H6 / CA
 [2009/07]
Representative(s)Swinkels, Bart Willem
Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS Den Haag / NL
[N/P]
Former [2009/07]Swinkels, Bart Willem
Nederlandsch Octrooibureau J. W. Frisolaan 13
2517 JS Den Haag / NL
Application number, filing date07719936.208.06.2007
[2009/07]
WO2007CA01020
Priority number, dateUS20060811766P08.06.2006         Original published format: US 811766 P
[2009/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007140619
Date:13.12.2007
Language:EN
[2007/50]
Type: A1 Application with search report 
No.:EP2021368
Date:11.02.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 13.12.2007 takes the place of the publication of the European patent application.
[2009/07]
Search report(s)International search report - published on:CA13.12.2007
(Supplementary) European search report - dispatched on:EP21.12.2009
ClassificationIPC:C07K14/62, A61K38/28, A61P3/10, A61P5/50
[2009/07]
CPC:
C07K14/62 (EP,US); A61P3/10 (EP); A61P5/50 (EP);
A61K38/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/07]
TitleGerman:DERIVATISIERTE INSULINOLIGOMERE[2009/07]
English:DERIVATIZED INSULIN OLIGOMERS[2009/07]
French:OLIGOMÈRES D'INSULINE DÉRIVÉS[2009/07]
Entry into regional phase05.12.2008National basic fee paid 
05.12.2008Search fee paid 
05.12.2008Designation fee(s) paid 
05.12.2008Examination fee paid 
Examination procedure05.12.2008Examination requested  [2009/07]
06.04.2010Despatch of a communication from the examining division (Time limit: M06)
14.10.2010Reply to a communication from the examining division
03.01.2013Application deemed to be withdrawn, date of legal effect  [2013/26]
06.02.2013Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2013/26]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.04.2010
Fees paidRenewal fee
19.05.2009Renewal fee patent year 03
31.03.2010Renewal fee patent year 04
13.06.2011Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.06.201206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US5053389  (BALSCHMIDT PER [DK], et al) [A] 1-12* the whole document *;
 [X]DE19535701  (DEUTSCHES WOLLFORSCHINST [DE]) [X] 1-12 * the whole document *
International search[A]US4705845  (CERAMI ANTHONY [US], et al);
 [A]US5242900  (ALBISSER A MICHAEL [CA]);
 [X]US5453417  (LOUGHEED WILLIAM D [CA])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.